Latest filing published 01 Sept 2020 for Rhythm Pharmaceuticals, INC., €144k.
Filing timeline
BuySaleInsider track record
Nithya Desikan: trading record in brief
All filings by Nithya Desikan on record concern Rhythm Pharmaceuticals, Inc. In total, 7 filings cover trades dated from 10 August 2018 to 31 August 2020.
No open-market purchase appears, only 2 sales worth €1.4M. Other entries cover 5 option exercises. 2020 to date brings no purchases and 1 sale.
The newest entry dates from 1 September 2020: an open-market sale of €628k, in Rhythm Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nithya Desikan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$6.888.0% of flowCommon StockSEC:0001104659-20-101370:0
- 25,000 shares@ US$30.0034.9% of flowCommon StockSEC:0001104659-20-101370:1
- 14,534 shares@ US$6.884.7% of flowCommon StockSEC:0001104659-20-094656:0
- 35,181 shares@ US$6.8811.0% of flowCommon StockSEC:0001104659-19-077301:0
- 35,181 shares@ US$22.7936.6% of flowCommon StockSEC:0001104659-19-077301:1
- 14,534 shares@ US$6.884.5% of flowCommon StockSEC:0001104659-19-045574:0
- 14,534 shares@ US$6.884.4% of flowCommon StockSEC:0001104659-18-051945:0
7 of 7 declarations
